期刊文献+

肝纤克对大鼠肝纤维化的影响 被引量:2

The Effects of the Mixture of GQK on Hepatocirrhosis in Experimental Rats
下载PDF
导出
摘要 目的 研究肝纤克(GQK)时实验性大鼠肝纤维化的保护作用。方法 以四氯化碳制备大鼠慢性肝纤维化模型,观察血清ALT,ALB,GLB含量;用放免法检测血清PC-Ⅲ,HA,LN,HYP含量以及肝组织中HYP含量,并计算出肝组织胶原含量。结果 ①GQK(0.5~1.0g/kg·po)使肝纤维化大鼠血清ALT明显下降(n=10,P〈0.01),ALB含量明显回升,A/G比值升高(n=10,P〈0.05),提示GQK时肝纤维化大鼠的肝功能有保护伤作用;②GQK使肝纤维化大鼠血清HYP明显下降(n=10,P〈0.05),肝组织HYP含量以及肝组织胶原含量也明显下降(n=10,P〈0.01);③GQK使肝纤维化大鼠血清PC-Ⅲ,HA及LN均明显下降(n=10,P〈0.01),提示GQK结四氧化碳致大鼠肝纤维化的过程有抑制作用。结论 GQK对实验性大鼠肝纤维化有明显的保护作用。 Objective To evaluate the protective action of the traditional Chinese mixture of Gan Qian Ke(GQK) on hepatocirrho- sis in experimental rats. Methods Hepatocirrhosis were induced by Tetrachloromathance (0. 1% - 10 ml/kg, ip)in rats. The levels of serum ALT ,ALB and GLB were examined by biochemistry. The levels of serum PC - Ⅲ ,HA、LA,HYP were also measured by radioimmunoassay. Results ①GQK(0.5 ~ 1.0 g/kg · po)could decerease the level of serum ALT( n = 10, P 〈 0. 01 )and increase the level of serum ALB of hepatocirrhosis rats, the A/G ration on the liver funtion ;②GQK could reduce the level of serum HYP( n = 10, P 〈 0.05 ) and hepatic tissue HYP ( n = 10, P 〈 0.01 ) ; ③The serum PC - Ⅲ, HA and LN of hepatocirrhosis rats were also lowered by GQK( n = 10, P 〈 0. 01 ) respectively. It indicates that GQK might inhibit the progress of hepatocirrhosis by Tetrachloromathane in rats. Conclusion These results suggested that GQK might possess the protective action on hepatoirrhosis in exeperimental rats.
作者 陈超
出处 《时珍国医国药》 CAS CSCD 北大核心 2006年第5期763-764,共2页 Lishizhen Medicine and Materia Medica Research
关键词 肝纤克 肝纤维化 Ⅲ型前胶原 透明质酸 GQK Hepatocirrhosis PC -Ⅲ HA
  • 相关文献

参考文献8

二级参考文献33

  • 1刘平,刘成,胡义杨,朱剑亮,薛惠明,徐列明.扶正化瘀方对肝炎后肝硬化的治疗作用[J].肝脏病杂志,1994,2(2):75-78. 被引量:17
  • 2王宝恩,赵洪涛,王泰玲,刘遵昌,贾继东,任万华.复方861对肝炎肝纤维化疗效的病理组织学分析[J].中华肝脏病杂志,1997,5(2):77-78. 被引量:58
  • 3[1]Wang Y Q, Ikeda K, Ikebe T, et al. Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats [J]. Hepatology, 2000, 32(5): 980-989.
  • 4[2]Hepatic Fibrosis Study Group of Chinese Liver Diseases Association. Consensus on evaluation of the diagnosis and efficacy of hepatic fibrosis [J]. Chin J Hepatology (中华肝脏病杂志), 2002, 10(5): 327-328.
  • 5[3]Nieto N, Friedman S L, Cederbaum A I. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species [J]. Hepatology, 2002, 35(1): 62-73.
  • 6[4]Tahashi Y, Matsuzaki K, Date M, et al. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury [J]. Hepatology, 2002, 35(1): 49-61.
  • 7[5]Dooley S, Delvoux B, Streckert M, et al. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGF beta signal transduction during transdifferentiation of hepatic stellate cells [J]. FEBS Lett, 2001, 502(1-2): 4-10.
  • 8[6]Patel K, Lajoie A, Heaton S, et al. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C [J]. J Gastroenterol Hepatol, 2003, 18(3): 253-257.
  • 9[7]Saegusa S, Isaji S, Kawarada Y. Changes in serum hyaluronic acid levels and expression of CD44 and CD44 mRNA in hepatic sinusoidal endothelial cells after major hepatectomy in cirrhotic rats [J]. World J Surg, 2002, 26(6): 694-699.
  • 10漆地芳.肝硬化[M].北京:科学技术出版社,2000.85.

共引文献115

同被引文献24

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部